This program offers a unique opportunity for 9 months of training at John Radcliffe Hospital, Oxford, followed by 3 months at Addenbrookes Hospital, Cambridge. The experience includes a wide range of clinical Hepatology exposure, educational opportunities, and participation in on-call rotation. The

0 views • 6 slides

Explore the detailed information about bilirubin metabolism and various types of jaundice, including their clinical presentations, etiologies, and management strategies. Learn to differentiate between different types of jaundice based on case scenarios and understand the functional anatomy and physi

0 views • 33 slides

Comprehensive overview of the EASL clinical practice guidelines on nutrition in chronic liver disease, first presented at the International Liver Congress 2018. These guidelines, published in the Journal of Hepatology, offer key recommendations and address unresolved issues in patient management. Ab

0 views • 49 slides

These slides provide a comprehensive overview of the EASL clinical practice guidelines on nutrition in chronic liver disease. The guidelines were first presented at the International Liver Congress 2018 and will soon be published in the Journal of Hepatology. The content covers methods of grading ev

6 views • 37 slides

Nottingham University Hospitals NHS Trust offers comprehensive Hepatology services at the Queen's Medical Centre, with a specialized team providing inpatient and outpatient care, liver transplants, viral hepatitis treatment, and advanced HPB endoscopy. The department is highly research-active and of

0 views • 10 slides

These slides provide a comprehensive overview of the EASL clinical practice guidelines for the management of acute (fulminant) liver failure, published in the May 2017 issue of the Journal of Hepatology. Covered topics include background, guidelines, key recommendations, and considerations for futur

0 views • 57 slides

Study on the efficacy of Daclatasvir and Sofosbuvir in treating Hepatitis C Virus (HCV) Genotype 3, involving treatment-naive and treatment-experienced patients. The Phase 3 trial showcased promising results in achieving SVR12, with detailed patient characteristics, drug dosing, and baseline charact

0 views • 10 slides